Ashburn Theodore

BalancedHigh Signal

CEOOncorus, Inc.·OfficerDicerna Pharmaceuticals IncCIK 0001627978

15 transactions·2 companies·Last Mar 1, 2022

$00 buys

$00 sells

50%/50%211K shares held ≈ $25K

Insider transactions by Ashburn Theodore

15 transactions — - in purchases, - in sales

Date	Via	Company	Type	Shares	Value
Mar 1, 22	Direct	ONCROncorus, Inc.	Grant	211 000	-
Nov 19, 21	Direct	ONCROncorus, Inc.	Exercise	32 500	-
Nov 19, 21	Direct	ONCROncorus, Inc.	Exercise	32 500	$58 825
Oct 22, 21	Direct	ONCROncorus, Inc.	Exercise	43 707	-
Oct 22, 21	Direct	ONCROncorus, Inc.	Exercise	43 707	$79 110
Apr 7, 21	Direct	ONCROncorus, Inc.	Exercise	4 699	-
Apr 7, 21	Direct	ONCROncorus, Inc.	Exercise	4 699	$24 999
Mar 1, 21	Direct	ONCROncorus, Inc.	Grant	199 000	-
Dec 31, 20	Direct	ONCROncorus, Inc.	Exercise	1 900	-
Dec 31, 20	Direct	ONCROncorus, Inc.	Exercise	1 900	$3 439
Oct 1, 20	Direct	ONCROncorus, Inc.	Grant	126 624	-
Jan 8, 16	Direct	DRNADicerna Pharmaceuticals Inc	Grant	75 000	-
Jan 9, 15	Direct	DRNADicerna Pharmaceuticals Inc	Grant	3 333	-
Dec 15, 14	Direct	DRNADicerna Pharmaceuticals Inc	Grant	115 000	-
Dec 15, 14	Direct	DRNADicerna Pharmaceuticals Inc	Grant	115 000	-

Direct = personal transaction

Via entity / trust / associate

Frequently asked questions about Ashburn Theodore

What are Ashburn Theodore's recent insider transactions?

Ashburn Theodore has filed 15 insider transactions across 2 companies, totaling $0 in purchases and $0 in sales. The most recent filing was on March 1, 2022.

Is Ashburn Theodore a net buyer or seller of shares?

Based on regulatory disclosures, Ashburn Theodore is a net seller with 0 purchases and 0 sales on record.

Ashburn Theodore

BalancedHigh Signal

CEOOncorus, Inc.·OfficerDicerna Pharmaceuticals IncCIK 0001627978

15 transactions·2 companies·Last Mar 1, 2022

$00 buys

$00 sells

50%/50%211K shares held ≈ $25K

Insider transactions by Ashburn Theodore

15 transactions — - in purchases, - in sales

Date	Via	Company	Type	Shares	Value
Mar 1, 22	Direct	ONCROncorus, Inc.	Grant	211 000	-
Nov 19, 21	Direct	ONCROncorus, Inc.	Exercise	32 500	-
Nov 19, 21	Direct	ONCROncorus, Inc.	Exercise	32 500	$58 825
Oct 22, 21	Direct	ONCROncorus, Inc.	Exercise	43 707	-
Oct 22, 21	Direct	ONCROncorus, Inc.	Exercise	43 707	$79 110
Apr 7, 21	Direct	ONCROncorus, Inc.	Exercise	4 699	-
Apr 7, 21	Direct	ONCROncorus, Inc.	Exercise	4 699	$24 999
Mar 1, 21	Direct	ONCROncorus, Inc.	Grant	199 000	-
Dec 31, 20	Direct	ONCROncorus, Inc.	Exercise	1 900	-
Dec 31, 20	Direct	ONCROncorus, Inc.	Exercise	1 900	$3 439
Oct 1, 20	Direct	ONCROncorus, Inc.	Grant	126 624	-
Jan 8, 16	Direct	DRNADicerna Pharmaceuticals Inc	Grant	75 000	-
Jan 9, 15	Direct	DRNADicerna Pharmaceuticals Inc	Grant	3 333	-
Dec 15, 14	Direct	DRNADicerna Pharmaceuticals Inc	Grant	115 000	-
Dec 15, 14	Direct	DRNADicerna Pharmaceuticals Inc	Grant	115 000	-

Direct = personal transaction

Via entity / trust / associate

Frequently asked questions about Ashburn Theodore

What are Ashburn Theodore's recent insider transactions?

Ashburn Theodore has filed 15 insider transactions across 2 companies, totaling $0 in purchases and $0 in sales. The most recent filing was on March 1, 2022.

Is Ashburn Theodore a net buyer or seller of shares?

Based on regulatory disclosures, Ashburn Theodore is a net seller with 0 purchases and 0 sales on record.